跳至主要内容
临床试验/NL-OMON28868
NL-OMON28868已完成不适用

Infection prevention and immune modulation by bacterial lysates: gaining insight into the mechanism of an old therapy.

Investigator initiated trial by clinical researchers of the Department of Pediatrics and Department of Pulmonology; Franciscus Gasthuis & Vlietland, Rotterdam0 个研究点目标入组 75 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
75

研究概览

简要总结

to follow

研究设计

研究类型
Interventional

入排标准

入选标准

  • Subjects aged 12-60 years with proven asthma (airway responsiveness proven by reversibility or histamine PC20 < 8 mg/ml)) who have recurrent airway signs and symptoms despite optimal maintenance medication (medium/high dose inhalation corticosteroid and long-acting ¦Â2-agonist; GINA 4).

排除标准

  • -Other relevant respiratory conditions, e.g. OSAS, bronchiectasis
  • -Systemic immunological diseases/systemic immunosuppression
  • -Current smoking or past smoking > 10 pack years
  • -Other untreated co-morbidity, such as gastro-esophageal reflux disease, ENT problems, psychological disorders
  • -Non-compliance to current medication or inhalation technique
  • -Communication difficulties
  • -Pregnancy or planned pregnancy within 2 years

研究者

发起方
Investigator initiated trial by clinical researchers of the Department of Pediatrics and Department of Pulmonology; Franciscus Gasthuis & Vlietland, Rotterdam

相似试验